--2025/Q1-- / 45.600M--
--2024/Q4-- / 43.033M--
Oct 30, 20242024/Q344.969M / 41.000M--
Jul 31, 20242024/Q237.205M / 48.233M--
May 8, 20242024/Q145.540M / 46.000M--
US Stock MarketDetailed Quotes
LAB Standard BioTools
- 1.500
- -0.080-5.06%
Close Nov 18 16:00 ET
558.39MMarket Cap-2173P/E (TTM)
1.580High1.480Low2.36MVolume1.570Open1.580Pre Close3.56MTurnover1.00%Turnover RatioLossP/E (Static)372.26MShares3.04052wk High1.14P/B355.81MFloat Cap1.21052wk Low--Dividend TTM237.21MShs Float49.455Historical High--Div YieldTTM6.33%Amplitude0.920Historical Low1.508Avg Price1Lot Size
Standard BioTools Key Stats
Standard BioTools Q3 2024 Earnings Date
Currency：USDOct 30, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 41.00M | 44.97M | +3.97M |
| Beat Est. | +61.63% | +77.27% | +9.68% |
| EPS | -0.09 | -0.07 | +0.02 |
| Beat Est. | +64.84% | +74.07% | +26.24% |
Analyst Rating
Oct 31, 2024
Standard BioTools Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Standard BioTools Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data